Search
for
Sort by
Research 91–120 of 790
- Ruxolitinib for the treatment of severe alopecia areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Alopecia areata
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Application of Baricitinib in Dermatology
- Citrullination at the Inflammatory Skin Barrier
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Spotlight in Plastic Surgery: October 2022
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring